Surgical Oncology: Tumor Removal and Staging Surgery

Surgical oncology is the branch of surgery dedicated to diagnosing, staging, and removing cancerous tumors, and it remains the primary curative intervention for the majority of solid tumor malignancies. This page covers the scope of surgical oncology as a discipline, the mechanisms by which tumor surgery is performed, the clinical settings in which it applies, and the criteria that guide operative decision-making. Understanding these principles is foundational to navigating the broader landscape of oncology care.

Definition and scope

Surgical oncology encompasses procedures performed with three distinct objectives: curative resection, staging, and palliation. The American College of Surgeons (ACS) Commission on Cancer defines the discipline as requiring specialized training that integrates oncologic principles — including tumor biology, margins assessment, and lymph node management — into surgical practice.

Surgical oncologists treat solid tumors arising in organs including the breast, colon, rectum, liver, pancreas, stomach, skin, and soft tissues. The subspecialty is distinct from general surgery in that every operative decision must account for tumor biology, regional lymphatic spread, and the likely need for adjuvant therapy. Surgeons completing a surgical oncology fellowship after residency receive training specifically in these integrated principles.

The scope intersects directly with the regulatory and credentialing frameworks described in the regulatory context for oncology, including accreditation standards set by the ACS Commission on Cancer, which accredits more than 1,500 cancer programs in the United States (ACS Commission on Cancer, Program Standards 2020).

How it works

Surgical oncology procedures follow a structured sequence that mirrors the phases of cancer diagnosis and treatment.

Biopsy and tissue sampling — Before definitive resection, histologic confirmation of malignancy is required. Techniques include core needle biopsy, excisional biopsy, and incisional biopsy. The National Cancer Institute (NCI) classifies these as diagnostic procedures distinct from therapeutic surgery.
Staging surgery — Operative staging establishes the anatomic extent of disease. Sentinel lymph node biopsy (SLNB), first standardized in the 1990s for melanoma and breast cancer by Morton and Krag respectively, identifies the first draining lymph node basin. A negative sentinel node reduces the probability of regional metastasis and may spare patients full axillary or inguinal dissection, limiting morbidity.
Curative resection — The surgeon removes the primary tumor with an oncologically adequate margin. The R-classification system, defined by the Union for International Cancer Control (UICC), categorizes margins as R0 (no residual tumor), R1 (microscopic residual), or R2 (macroscopic residual). R0 resection is the standard target for curative intent.
Reconstruction — Following resection, reconstructive procedures restore function or form. Breast reconstruction after mastectomy and flap reconstruction after head and neck resection are established components of the operative plan.
Pathologic evaluation — Resected specimens are submitted to pathology for margin assessment, lymph node analysis, and tumor characterization, producing the final pathologic TNM stage per American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 8th Edition.

Minimally invasive approaches — laparoscopic and robotic-assisted surgery — have expanded to colectomy, gastrectomy, and prostatectomy. The National Comprehensive Cancer Network (NCCN) guidelines for each disease site specify when minimally invasive approaches are considered equivalent to open surgery for oncologic outcomes.

Common scenarios

Surgical oncology is the primary treatment modality in several high-incidence cancer types:

Breast cancer — Lumpectomy (breast-conserving surgery) or mastectomy, combined with SLNB. NCCN guidelines indicate that lumpectomy followed by radiation is equivalent in survival to mastectomy for early-stage disease in eligible patients.
Colorectal cancer — Segmental colectomy with mesorectal excision for rectal cancers. The total mesorectal excision (TME) technique, associated with surgeon Bill Heald, reduced local recurrence rates from above 30% to below 10% in controlled series.
Pancreatic cancer — Pancreaticoduodenectomy (Whipple procedure) for tumors of the pancreatic head. Only approximately 20% of pancreatic cancer patients present with resectable disease at diagnosis (NCI Surveillance, Epidemiology, and End Results SEER Program).
Melanoma — Wide local excision with margins of 1–2 cm depending on Breslow depth, combined with SLNB for tumors exceeding 0.8 mm thickness per NCCN melanoma guidelines.
Liver metastases — Hepatic resection for colorectal liver metastases in patients with adequate hepatic reserve, increasingly guided by intraoperative ultrasound.

Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) represents a specialized scenario for peritoneal surface malignancies, including appendiceal and ovarian cancers with peritoneal spread.

Decision boundaries

Not all patients with resectable tumors are surgical candidates. Operative decision-making is governed by four primary criteria:

Resectability — Defined by the absence of involvement of critical vascular structures, adequate surgical margins, and absence of unresectable distant metastases. Borderline resectable disease, as defined in NCCN pancreatic cancer guidelines, may require neoadjuvant chemotherapy or radiation before surgical reassessment.

Functional reserve — Hepatic, pulmonary, and cardiac reserve must meet minimum thresholds. Preoperative pulmonary function testing is required before pulmonary resection; FEV1 and diffusing capacity for carbon monoxide (DLCO) below 40% predicted are relative contraindications per thoracic surgery literature.

Performance status — The Eastern Cooperative Oncology Group (ECOG) performance scale (0–5) is the standard instrument. Patients with ECOG scores of 3 or 4 are generally not candidates for major oncologic resection.

Curative vs. palliative intent — Surgery performed for palliation — such as colostomy for obstructing rectal cancer or debulking for ovarian carcinoma — follows different decision criteria than curative resection. Palliative surgery aims to relieve symptoms or extend survival without the strict margin requirements of curative procedures.

Multidisciplinary tumor boards, a structural requirement of ACS Commission on Cancer accreditation, review cases at decision boundaries to integrate surgical, medical oncology, radiation oncology, radiology, and pathology input before operative recommendations are finalized.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)